Alterity Therapeutics Limited (ATHE)

NASDAQ: ATHE · Real-Time Price · USD

4.880

-0.260 (-5.06%)

At close: Jun 18, 2026, 4:00 PM EDT

4.990

+0.110 (2.25%)

After-hours: Jun 18, 2026, 6:30 PM EDT

Alterity Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 18, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Cap	92	62	16	11	24	45
Market Cap Growth	117.80%	293.93%	39.21%	-53.63%	-45.81%	-78.05%
Enterprise Value	57.19	40.51	7.47	0.98	0.54	24.12
Last Close Price	4.88	204.50	90.34	139.50	305.00	650.00
PS Ratio	20.71	12.38	5.89	4.35	6.92	13.43
PB Ratio	2.53	2.23	1.72	0.75	1.00	1.98
P/TBV Ratio	-	1.03	0.80	0.50	0.69	1.21
EV/Sales Ratio	12.92	8.06	2.78	0.37	0.15	7.17
Debt / Equity Ratio	-	0.00	0.00	0.00	0.00	0.00
Net Debt / Equity Ratio	-	-0.78	-0.90	-0.68	-0.98	-0.92
Net Debt / EBITDA Ratio	-	2.68	0.64	1.07	2.25	1.86
Net Debt / FCF Ratio	-	2.88	0.99	0.78	2.79	1.62
Asset Turnover	-	0.23	0.17	0.11	0.14	0.21
Quick Ratio	-	10.49	3.10	5.58	6.79	10.56
Current Ratio	-	12.98	3.54	6.17	7.07	10.92
Return on Equity (ROE)	-	-42.75%	-103.97%	-46.66%	-38.54%	-81.39%
Return on Assets (ROA)	-	-37.97%	-84.05%	-42.40%	-41.14%	-69.73%
Return on Invested Capital (ROIC)	-	-228.35%	-448.04%	-358.72%	-948.65%	-1196.60%
Return on Capital Employed (ROCE)	-	-44.23%	-106.60%	-50.17%	-46.93%	-80.42%
Buyback Yield / Dilution	-74.72%	-75.31%	-50.29%	-0.91%	-41.79%	-89.62%
Total Shareholder Return	-74.72%	-75.31%	-50.29%	-0.91%	-41.79%	-89.62%

SEC Filings: 10-K · 10-Q